NEUROPHET, Inc. (KOSDAQ:380550)
20,700
-300 (-1.43%)
Apr 29, 2026, 3:30 PM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 253.93 billion as of April 28, 2026.
Market Cap
253.93B
Enterprise Value
235.69B
Revenue
2.62B
Ranking
n/a
PE Ratio
n/a
Stock Price
20,700.00
Market Cap Chart
Since July 25, 2025, NEUROPHET's market cap has increased from 232.96B to 253.93B, an increase of 9.00%. That is a compound annual growth rate of 12.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 253.93B | -1.93% |
| Dec 30, 2025 | 258.91B | 11.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 70.73T |
| Celltrion | 43.80T |
| ALTEOGEN | 19.75T |
| Samsung Epis Holdings | 14.28T |
| CMG Pharmaceutical | 269.37B |
| JETEMA, | 267.91B |
| EASY BIO,Inc. | 264.66B |
| Genexine | 258.32B |